Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer

Plain-language summary

This study aims to examine muscle dysfunction in patients with gastrointestinal or hepatobiliary (liver and bile-duct) cancer. It enrolls patients aged 18 and older with histologically confirmed cancer of this type. The trial is a non-phase study and is active but not currently recruiting.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Active, not recruiting

Sponsor

Rigshospitalet, Denmark

Start date

12/1/2017

Estimated completion

12/31/2026

Countries

Denmark

Related genes

Locations

• Copenhagen, Denmark

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Patients diagnosed with histologically verified GI-HEP cancer

Exclusion Criteria:

* Age: \<18
* Pregnancy
* Physical or mental disabilities precluding physical testing
* Inability to read and understand Danish